Heterocyclic Diamidine DNA Ligands as HOXA9 Transcription Factor Inhibitors: Design, Molecular Evaluation, and Cellular Consequences in a HOXA9-Dependant Leukemia Cell Model

导出原文传递

翻译打印收藏纠错

作者： Depauw, Sabine ^[1] ; Lambert, Melanie ^[2] ; Jambon, Samy ^[2] ; Paul, Ananya ^[1] ; Peixoto, Paul ^[1] ; Nhili, Raja ^[2] ; Marongiu, Laura ^[2] ; Figeac, Martin ^[2] ; Dassi, Christelle ^[2] ; Paul-Constant, Charles ^[1] ; Billore, Benjamin ^[3] ; Kumar, Arvind ^[3] ; Farahat, Abdelbasset A. ^[2] ; Ismail, Mohamed A. ^[2] ; Mineva, Ekaterina ^[1] ; Sweat, Daniel P. ^[1] ; Stephens, Chad E. ^[2] ; Boykin, David W. ^[1] ; Wilson, W. David ^[2] ; David-Cordonnier, Marie-Helene ^[4]

作者单位： Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA ^[1] Univ Lille, CHU Lille, INSERM, IRCL,JPARC,UMR S1172, F-59045 Lille, France ^[2] Augusta Univ, Dept Chem & Phys, Augusta, GA 30904 USA ^[3] Lille Univ, Funct & Struct Genom Platform, F-59000 Lille, France ^[4]

发布时间 2019-08-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of Medicinal Chemistry

2019年62卷3期

1306-1329页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Heterocyclic Diamidine DNA Ligands as HOXA9 Transcription Factor Inhibitors: Design, Molecular Evaluation, and Cellular Consequences in a HOXA9-Dependant Leukemia Cell Model

Journal of Medicinal Chemistry

相似文献

Journal of Medicinal Chemistry

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Heterocyclic Diamidine DNA Ligands as HOXA9 Transcription Factor Inhibitors: Design, Molecular Evaluation, and Cellular Consequences in a HOXA9-Dependant Leukemia Cell Model

Journal of Medicinal Chemistry

相似文献

Journal of Medicinal Chemistry

相关期刊

检索历史清除